DS&R conducted two independent studies at two hospitals using the Healthcare Innovation Performance Assessment (Healthcare IPA©). The studies a showed a significant reduction in length of stay, readmission rates and patient outcomes, as well an estimated savings of $17,355¹ and $56,071² per patient per year. A cost calculator was developed form the data to enable the sales team to demonstrate the benefits at specific hospitals using local data.
The publications provided additional tools to help sales team show the benefits to target accounts. Administrators, hospital pharmacists and clinicians used the data and calculator project the impact of the therapy using local variables. Applying DS&R’s proven process helps grow sales by accelerating product adoption. Sales were significantly increased as a result of this approach.
¹ Koczerginski & Arshoff, Hospital Resource Use by Patients with Schizophrenia: Reduction after Conversion form Oral Treatment to Risperidone Long Acting Injection, Healthcare Quarterly 2011:14 (1): 82-87
² Lalla & Arshoff, A mental health initiative to enhance schizophrenia treatment efficacy, Healthcare Management Forum 2013:26(1): 46-50
